Literature DB >> 9153307

DNA strand transfer reactions catalyzed by vaccinia topoisomerase: hydrolysis and glycerololysis of the covalent protein-DNA intermediate.

B O Petersen1, S Shuman.   

Abstract

Vaccinia topoisomerase forms a covalent protein-DNA intermediate at sites containing the sequence 5'-CCCTT. The T nucleotide is linked via a 3'-phosphodiester bond to Tyr-274 of the enzyme. Here, we report that the enzyme catalyzes hydrolysis of the covalent intermediate, resulting in formation of a 3'-phosphate-terminated DNA cleavage product. The hydrolysis reaction is pH-dependent (optimum pH = 9.5) and is slower, by a factor of 10(-5), than the rate of topoisomerase-catalyzed strand transfer to a 5'-OH terminated DNA acceptor strand. Mutants of vaccinia topoisomerase containing serine or threonine in lieu of the active site Tyr-274 form no detectable covalent intermediate and catalyze no detectable DNA hydrolysis. This suggests that hydrolysis occurs subsequent to formation of the covalent protein-DNA adduct and not via direct attack by water on DNA. Vaccinia topoisomerase also catalyzes glycerololysis of the covalent intermediate. The rate of glycerololysis is proportional to glycerol concentration and is optimal at pH 9.5.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9153307      PMCID: PMC146705          DOI: 10.1093/nar/25.11.2091

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  20 in total

1.  Covalent DNA binding by vaccinia topoisomerase results in unpairing of the thymine base 5' of the scissile bond.

Authors:  J Sekiguchi; S Shuman
Journal:  J Biol Chem       Date:  1996-08-09       Impact factor: 5.157

2.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction.

Authors:  S N Ho; H D Hunt; R M Horton; J K Pullen; L R Pease
Journal:  Gene       Date:  1989-04-15       Impact factor: 3.688

3.  Requirements for noncovalent binding of vaccinia topoisomerase I to duplex DNA.

Authors:  J Sekiguchi; S Shuman
Journal:  Nucleic Acids Res       Date:  1994-12-11       Impact factor: 16.971

4.  Characterization of vaccinia virus DNA topoisomerase I expressed in Escherichia coli.

Authors:  S Shuman; M Golder; B Moss
Journal:  J Biol Chem       Date:  1988-11-05       Impact factor: 5.157

5.  Histidine 265 is important for covalent catalysis by vaccinia topoisomerase and is conserved in all eukaryotic type I enzymes.

Authors:  B O Petersen; S Shuman
Journal:  J Biol Chem       Date:  1997-02-14       Impact factor: 5.157

6.  Peptide sequencing and site-directed mutagenesis identify tyrosine-727 as the active site tyrosine of Saccharomyces cerevisiae DNA topoisomerase I.

Authors:  R M Lynn; M A Bjornsti; P R Caron; J C Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

7.  Mutational analysis of 39 residues of vaccinia DNA topoisomerase identifies Lys-220, Arg-223, and Asn-228 as important for covalent catalysis.

Authors:  C Cheng; L K Wang; J Sekiguchi; S Shuman
Journal:  J Biol Chem       Date:  1997-03-28       Impact factor: 5.157

8.  Vaccinia DNA topoisomerase I: kinetic evidence for general acid-base catalysis and a conformational step.

Authors:  J T Stivers; S Shuman; A S Mildvan
Journal:  Biochemistry       Date:  1994-12-27       Impact factor: 3.162

9.  Vaccinia topoisomerase binds circumferentially to DNA.

Authors:  J Sekiguchi; S Shuman
Journal:  J Biol Chem       Date:  1994-12-16       Impact factor: 5.157

10.  DNA is linked to the rat liver DNA nicking-closing enzyme by a phosphodiester bond to tyrosine.

Authors:  J J Champoux
Journal:  J Biol Chem       Date:  1981-05-25       Impact factor: 5.157

View more
  5 in total

1.  DNA strand transfer catalyzed by vaccinia topoisomerase: ligation of DNAs containing a 3' mononucleotide overhang.

Authors:  C Cheng; S Shuman
Journal:  Nucleic Acids Res       Date:  2000-05-01       Impact factor: 16.971

2.  Vaccinia topoisomerase and Cre recombinase catalyze direct ligation of activated DNA substrates containing a 3'-para-nitrophenyl phosphate ester.

Authors:  G Woodfield; C Cheng; S Shuman; A B Burgin
Journal:  Nucleic Acids Res       Date:  2000-09-01       Impact factor: 16.971

3.  Unmasking Anticooperative DNA-binding interactions of vaccinia DNA topoisomerase I.

Authors:  Rajesh Nagarajan; James T Stivers
Journal:  Biochemistry       Date:  2007-01-09       Impact factor: 3.162

4.  Replacement of the active site tyrosine of vaccinia DNA topoisomerase by glutamate, cysteine or histidine converts the enzyme into a site-specific endonuclease.

Authors:  J Wittschieben; B O Petersen; S Shuman
Journal:  Nucleic Acids Res       Date:  1998-01-15       Impact factor: 16.971

5.  Poxviruses as Gene Therapy Vectors: Generating Poxviral Vectors Expressing Therapeutic Transgenes.

Authors:  Steven J Conrad; Jia Liu
Journal:  Methods Mol Biol       Date:  2019
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.